Bilimsel çalışmalar

Doç. Dr. Sevil Sadri

64 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study

    Journal of Thrombosis and Thrombolysis, 2026

    DOI 10.1007/s11239-026-03363-8 PMID 42565930 Açık erişimli tam metinKaynak: OpenAlex

  2. Time-Dependent Prognostic Value of the mEASIX Score in Patients with Myelodysplastic Syndromes

    Diagnostics, 2026

    DOI 10.3390/diagnostics16111640 PMID 42279509 Açık erişimli tam metinKaynak: ORCID

  3. Probable sarcopenia and bone health in transfusion-dependent beta thalassemia patients

    Hematology, 2026

    DOI 10.1080/16078454.2026.2712127 PMID 42550149 Açık erişimli tam metinKaynak: OpenAlex

  4. Association of the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score With Renal Recovery in Newly Diagnosed Multiple Myeloma: A Retrospective Study

    The European Research Journal, 2026

    DOI 10.18621/eurj.1399 Açık erişimli tam metinKaynak: ORCID

  5. Eltrombopag for Chemotherapy-Induced Thrombocytopenia: A Multicenter Retrospective Real-World Study

    Hematology Reports, 2026

    DOI 10.3390/hematolrep18030039 PMID 42345735 Açık erişimli tam metinKaynak: ORCID

  6. Evaluation of Dermatological Lesions in Patients With Hematologic Malignancy

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2026

    DOI 10.32708/uutfd.1782776 Açık erişimli tam metinKaynak: ORCID

  7. Clinical practice of the endothelial activation and stress index and its modified versions in multiple myeloma and the effects on prognosis

    Therapeutic Advances in Hematology, 2026

    DOI 10.1177/20406207251387409 PMID 41509514 5 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  8. Kaposi Sarcoma Presenting as Hemophagocytic Lymphohistiocytosis Mimicking Infection and Lymphoma: A Diagnostic Challenge

    Cureus, 2026

    DOI 10.7759/cureus.105780 PMID 42037832 Açık erişimli tam metinKaynak: OpenAlex

  9. PB1736 A single-center retrospective study of thrombosis and procedural outcomes in hospitalized patients receiving therapeutic plasma exchange

    Research and Practice in Thrombosis and Haemostasis, 2026

    DOI 10.1016/j.rpth.2026.104598 Açık erişimli tam metinKaynak: OpenAlex

  10. MİYELOPROLİFERATİF NEOPLAZMLARDA SPLANKNİK VEN TROMBOZUNUN DEĞERLENDİRİLMESİ: THD KRONİK MİYELOSİTER LÖSEMİ VE KRONİK MİYELOPROLİFERATİF NEOPLAZMLAR VE HEMOSTAZ - TROMBOZ BİLİMSEL ALT KOMİTELERİ ÇOK MERKEZ ÇALIŞMASI

    Kocaeli Üniversitesi - AVESİS, 2025

    Kaynak: OpenAlex

  11. Arterial Thrombosis in Patients with Primary Immune Thrombocytopenia: A Nationwide Study

    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025

    DOI 10.4274/tjh.galenos.2025.2025.0268 PMID 40859646 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

  12. Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye

    Diagnostics, 2025

    DOI 10.3390/diagnostics15050633 PMID 40075881 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  13. Validation and interpretation of the Triple A model in Turkish myeloproliferative neoplasm patients with a focus on overall and thrombosis free survival

    Journal of Hematopathology, 2025

    DOI 10.1007/s12308-025-00668-0 PMID 41193887 Kaynak: OpenAlex

  14. Miyelodisplastik Sendromda Venetoklaks Tedavisi Gerçek Yaşam Verisi: Türk Hematoloji Derneği Lösemi Çalışma Grubu

    AYBU AVESIS, 2024

    Kaynak: OpenAlex

  15. HALP score as a novel prognostic factor for patients with myelodysplastic syndromes

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-64166-6 PMID 38879594 14 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  16. Elevated Plasma Atherogenic and Triglyceride-Glucose Indices: Markers of Cardiovascular Risk in Transfusion-Dependent Thalassemia

    Hemoglobin, 2024

    DOI 10.1080/03630269.2024.2412111 PMID 39410756 1 atıf (Europe PMC) Kaynak: ORCID

  17. Is HALP score a predictor of poor prognosis in patients with hematologic malignancies admitted to the intensive care unit?

    The Egyptian Journal of Internal Medicine, 2024

    DOI 10.1186/s43162-024-00339-z 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  18. Evaluation of Prognostic Factors Associated with Intensive Care Unit Mortality in Patients with Hematopoietic Stem Cell Transplantation

    2024

    DOI 10.22541/au.170666088.84785939/v1 Açık erişimli tam metinKaynak: ORCID

  19. Investigation of Depression, Anxiety, Sleep Quality, and Fatigue in Thalassemia Major Patients: A Study of the Correlation Between Sleep Quality and Laboratory Findings

    Cureus, 2024

    DOI 10.7759/cureus.72614 PMID 39610629 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  20. THE IMPORTANCE OF CLINICAL AND LABORATORY PARAMETERS OF BONE MARROW METASTASIS IN PATIENTS WITH SOLID MALIGNANCY-SINGLE CENTER EXPERIENCE

    Karya Journal of Health Science, 2023

    DOI 10.52831/kjhs.1271864 Açık erişimli tam metinKaynak: OpenAlex

  21. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

    The European Research Journal, 2023

    DOI 10.18621/eurj.1231251 Açık erişimli tam metinKaynak: OpenAlex

  22. Prevalence and risk factors of osteoporosis and osteoarthritis among Beta Thalassemia patients

    Medical Science and Discovery, 2023

    DOI 10.36472/msd.v10i3.895 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  23. The role of obesity on autologous bone marrow transplant and post-transplant outcomes

    Journal of Surgery and Medicine, 2023

    DOI 10.28982/josam.7664 Açık erişimli tam metinKaynak: ORCID

  24. Do neutrophil–lymphocyte ratio and platelet–lymphocyte ratio have a role in determining mortality in intensive care patients undergoing plasmapheresis? Single‐center experience

    Therapeutic Apheresis and Dialysis, 2023

    DOI 10.1111/1744-9987.13900 PMID 35730341 Kaynak: ORCID

  25. Evaluation of acquired and hereditary risk factors for the development of thromboembolism in patients with systemic lupus erythematosus

    Blood Coagulation & Fibrinolysis, 2023

    DOI 10.1097/mbc.0000000000001253 PMID 37756208 1 atıf (Europe PMC) Kaynak: ORCID

  26. The value of the systemic immune inflammation index (SII) in migraine patients treated with greater occipital block treatment

    SANAMED, 2023

    DOI 10.5937/sanamed0-44601 Açık erişimli tam metinKaynak: ORCID

  27. What is the best treatment for anemia in pregnant women in the third trimester: Ferric carboxymaltose or oral iron therapy?

    Annals of Medical Research, 2023

    DOI 10.5455/annalsmedres.2023.09.246 Açık erişimli tam metinKaynak: OpenAlex

  28. Comparison of Efficacy and Safety of Generic Plerixafor Vs Original Plerixafor in the Mobilization of Myeloma Patients

    Blood, 2022

    DOI 10.1182/blood-2022-168558 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  29. Hematolojide Güncel Yaklaşımlar

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1547 Açık erişimli tam metinKaynak: OpenAlex

  30. Evaluation of Neurological Imaging After Hematopoietic Stem Cell Transplantation In Adults

    Eastern Journal of Medicine, 2022

    DOI 10.5505/ejm.2022.54765 Açık erişimli tam metinKaynak: ORCID

  31. Kronik Lenfositik Lösemi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1209 Açık erişimli tam metinKaynak: OpenAlex

  32. The Relationship of Body Mass Index with Platelet Counts and Donation Frequency of Platelet Apheresis Donors

    Düzce Tıp Fakültesi Dergisi, 2022

    DOI 10.18678/dtfd.1058458 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  33. Evaluation of prognostic factors associated with intensive care unit mortality in patients with hematopoietic stem cell transplantation

    Anaesthesia Pain & Intensive Care, 2022

    DOI 10.35975/apic.v26i4.1951 Açık erişimli tam metinKaynak: ORCID

  34. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

    Turkish Journal of Hematology, 2021

    DOI 10.4274/tjh.galenos.2021.2021.0287 PMID 34521187 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  35. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/j.clml.2021.04.005 PMID 34052176 6 atıf (Europe PMC) Kaynak: OpenAlex

  36. Rare side effect caused by atezolizumab, an immune checkpoint inhibitor: Cold agglutinin disease

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/10781552211033009 PMID 34282980 3 atıf (Europe PMC) Kaynak: ORCID

  37. OUTCOME AND PROGNOSTIC FACTORS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY ADMITTED TO AN INTENSIVE CARE UNIT: A SINGLE-CENTER STUDY

    DergiPark (Istanbul University), 2020

    1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  38. A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia

    Turkish Journal of Hematology, 2019

    DOI 10.4274/tjh.galenos.2019.2018.0307 PMID 31327186 15 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  39. Adult Case Series of Extramedullary Relapsing Acute Myeloid Leukemia (AML) after Allogeneic Stem Cell Transplantation in Whom a Rapid Response and a Reasonably Long Remission Could be Achieved with Gemtuzumab Ozogamycin (GO)

    BLOOD, 2019

    DOI 10.1182/blood-2019-126195 1 atıf (OpenAlex) Kaynak: ORCID

  40. The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations

    Clinical Lymphoma Myeloma and Leukemia, 2019

    DOI 10.1016/j.clml.2019.03.028 PMID 31088736 4 atıf (Europe PMC) Kaynak: ORCID

  41. Osteoporosis in Patients With Hemophilia: Single-Center Results From a Middle-Income Country

    Clinical and Applied Thrombosis/Hemostasis, 2019

    DOI 10.1177/1076029619861689 PMID 31282181 12 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  42. Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

    Blood, 2019

    DOI 10.1182/blood-2019-130305 2 atıf (OpenAlex) Kaynak: OpenAlex

  43. Participation in Physical and Sportive Activities among Adult Turkish People with Hemophilia: A Single-Center Experience

    The Turkish Journal of Hematology, 2018

    DOI 10.4274/tjh.2017.0292 PMID 28920578 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  44. Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience

    Balkan Medical Journal, 2018

    DOI 10.4274/balkanmedj.2017.1215 PMID 29966997 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  45. Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience

    Kocaeli Üniversitesi - AVESİS, 2017

    Kaynak: OpenAlex

  46. Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

    Clinical Lymphoma Myeloma and Leukemia, 2017

    DOI 10.1016/j.clml.2017.07.255 PMID 28847475 15 atıf (Europe PMC) Kaynak: ORCID

  47. Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

    Blood, 2017

    DOI 10.1182/blood.v130.suppl_1.2888.2888 1 atıf (OpenAlex) Kaynak: OpenAlex

  48. Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience

    Blood, 2017

    DOI 10.1182/blood.v130.suppl_1.5349.5349 1 atıf (OpenAlex) Kaynak: OpenAlex

  49. Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience

    Bursa Uludag University - AVESIS, 2017

    Kaynak: OpenAlex

  50. Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia

    Blood, 2016

    DOI 10.1182/blood.v128.22.1905.1905 Kaynak: OpenAlex